Featured publication

Publications

CADRE publications for 2024 (in progress)

Archer DB et al. “Longitudinal change in memory performance as a strong endophenotype for Alzheimer’s disease.” Alz Dement. 2024; PMID: 37985223

Cheng F et al. “Aritficial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease.” Cell Rep Med. 2024; PMID: 38382465

Eissman JM et al. “Sex-specific genetic architecture of late-life memory performance.” Alz Dement. 2024; PMID: 37984853

Leung YY et al. “Human whole-exome genotype data for Alzheimer’s disease.” Nat Commun. 2024; PMID: 38263370

Malamon JS et al. “A comparative study of structural variant calling in WGS from Alzheimer’s disease families.” Life Sci Alliance. 2024; PMID: 38418088

Nuytemans K et al. “Genetic analyses in mulitplex families confirms chromosome 5q35 as a risk locus for Alzehimer’s Disease in individuals of African Ancestry.” Neurobiol Aging. 2024; PMID: 37952397

Tejeda M et al. “DNA from multiple viral species is associated with Alzheimer’s disease risk.” Alzheimers Dement. 2024; PMID: 37578203

Vance JM et al. “Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer’s Disease.” Ann Neurol. 2024; PMID: 38180638

Wang, H et al. “The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases.” Front Aging Neurosci. 2023; PMID: 36846102

Wang P et al. “Genome-wide association studies identify novel loci in rapidly progressive Alzheimer’s disease.” Alz Dement. 2024; PMID: 38184787

Zhang X et al. “An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer’s Disease.” J Alzheimers Dis. 2024; PMID: 38489177

Zhu C et al. “MitoH3: Mitochondrial Haplogroup and Homoplasmic/Heteroplasmic Variant Calling Pipeline for Alzheimer’s Disease Sequencing Project.” J Alzheimers Dis Rep. 2024; PMID: 38746629

CADRE publications for 2023 

Bai H et al. “A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer’s disease.” Alzheimers Dement. 2023; PMID: 37051669

Celis K et al. “Neuropsychiatric features in a multi-ethnic population with Alzheimer disease and mild cognitive impairment.” Int J Geriatr Psychiatry. 2023; PMID: 37655494

Chung J et al. “Alzheimer’s disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.” Alz Dement. 2023; PMID: 37166019

Felsky D et al. “The Caribbean-Hispanic Alzheimer’s disease brain transcriptome reveals ancestry-specific disease mechanisms.” Neurobiol Dis. 2023; PMID: 36462719

Gao XR et al. “Explainable machine learning aggregates polygenic risk scores and electronic health records for Alzheimer’s disease prediction.” Sci Rep. 2023; PMID: 36624143

Kang M et al. “A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores.” Mol Neurodegener. 2023; PMID: 37349795

Le Guen Y et al. “Association of African Ancestry-Specific APOE Missense Variant R145C With Risk of Alzheimer Disease.” JAMA. 2023; PMID: 36897323

Li D et al. “Novel loci for Alzheimer’s disease identified by a genome-wide association study in Ashkenazi Jews.” [published online ahead of print, 2023 Jun 1]. Alzheimers Dement. 2023; PMID: 37260021

Li YJ et al. “Identification of novel genes for age-at-onset of Alzheimer’s disease by combining quantitative and survival trait analyses.” Alzheimers Dement. 2023; PMID: 36738287

Logue MW, Dasgupta S, Farrer LA. “Genetics of Alzheimer’s Disease in the African American Population.” J Clin Med. 2023; PMID: 37629231

Osterman MD et al. “Founder population-specific weights yield improvements in performance of polygenic risk scores for Alzheimer’s disease in the Midwestern Amish.” HGG Adv. 2023; PMID: 37742071

Prough MB et al. “Visuospatial and Verbal Memory Differences in Amish Individuals With Alzheimer Disease and Related Dementias.” Alzheimer Dis Assoc Disord. 2023; PMID: 37561946

Qiao M et al. “Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease.” Ann Clin Transl Neurol. 2023; PMID: 36946865

Reitz C et al. “A global view of the genetic basis of Alzheimer disease.” Nat Rev Neurol. 2023; PMID: 37024647

Sherva R et al. “African ancestry GWAS of dementia in a large military cohort identifies significant risk loci.” Mol Psychiatry. 2023; PMID: 36543923

Walters S et al. “Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults.” JAMA Neurol. 2023; PMID: 37459083

Wang H et al. “The role of structural variations in Alzheimer’s disease and other neurodegenerative diseases.” Front Aging Neurosci. 2023; PMID: 36846102

Zaman A et al. “Psychometric approaches to defining cognitive phenotypes in the Old Order Amish.” Int J Geriatr Psychiatry. 2023; PMID: 36929524

Zhang W et al. “Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects.” Alzheimers Res Ther. 2023; PMID: 37038196

Zhang X et al. “Midlife lipid and glucose levels are associated with Alzheimer’s disease.” Alzheimers Dement. 2023; PMID: 35319157

CADRE publications for 2022

Bellenguez C et al. “New insights into the genetic etiology of Alzheimer’s disease and related dementias.” Nat Genet. 2022; PMID: 35379992

Chung J et al. “Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer’s disease among women.” [published online ahead of print, 2022 Jun 30]. Alzheimers Dement. 2022; PMID: 35770850

Eissman JM et al. “Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease.” Brain. 2022; PMID: 35552371

Gardner OK et al. “Genetic architecture of RNA editing regulation in Alzheimer’s disease across diverse ancestral populations.” Hum Mol Genet. 2022; PMID: 35383839

Godrich D, et al. “Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population.” Alzheimers Dement. 2022; PMID: 35142102

Heath L et al. “Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90.” Sci Rep. 2022; PMID: 35413975

Holstege et al. “Exome sequencing identified rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzhiemer’s disease.” Nature Genetics. 2022; PMID: 36411364

Jin B et al. “An association test of the spatial distribution of rare missense variants within protein structures identifies Alzheimer’s disease-related patterns.” Genome Res. 2022; PMID: 35210353

Jun GR et al. “Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer’s disease.” Alzheimers Dement. 2022; PMID: 35142023

Kizil C et al. “Admixture Mapping of Alzheimer’s disease in Caribbean Hispanics identifies a new locus on 22q13.1.” Mol Psychiatry. 2022; PMID: 35365809

Nuytemans K et al. “Identifying differential regulatory control of APOE e4 on African versus European haplotypes as potential therapeutic targets.” Alzheimers Dement. 2022; PMID: 34978147

Olayinka OA, O’Neill NK, Farrer LA, Wang G, Zhang X. “Molecular Quantitative Trait Locus Mapping in Human Complex Diseases.” Curr Protoc. 2022; PMID: 35587224

Osterman MD et al. “The genetic architecture of Alzheimer disease risk in the Ohio and Indiana Amish.” HGG Adv. 2022; PMID: 35599847

Panitch R et al. “Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease.” Alzheimers Res Ther. 2022; PMID: 35139885

Rajabli F et al. “A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer’s Disease in African Ancestry.” PLoS Genet. 2022; PMID: 35788729

Rajabli F et al. “Admixture mapping identifies novel Alzheimer’s disease risk regions in African Americans.” Alzheimers Dement. 2022; PMID: 36539198

Ramos J et al. “Genetic variants in the SHISA6 gene are associated with delayed cognitive impairment in two family datasets.” Alzheimers Dement. 2022; PMID: 35490390

Vardarajan BN et al. “Progranulin mutations in clinical and neuropathological Alzheimer’s disease.” Alzheimers Dement. 2022; PMID: 35258170

CADRE publications for 2021

Andrews SJ et al. “Causal Associations Between Modifiable Risk Factors and the Alzheimer’s Phenome.” Ann Neurol 2021; PMID: 32996171

de Rojas I et al. “Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores.” Nat Commun. 2021; PMID: 34099642

Griswold AJ*, Celis K* et al. “Increased APOE ε4 expression is associated with the difference in Alzheimer’s disease risk from diverse ancestral backgrounds.” Alzheimers Dement. 2021; PMID: 33522086

Lee WP et al. “Copy Number Variation Identification on 3,800 Alzheimer’s Disease Whole Genome Sequencing Data from the Alzheimer’s Disease Sequencing Project.” Front Genet. 2021; PMID: 34804120

Marca-Ysabel MV et al. “Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population.” Neurobiol Aging. 2021; PMID: 33541779

Panitch R et al. “Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease.” Mol Psychiatry. 2021; PMID: 34480088

Patel D et al. “Set-Based Rare Variant Expression Quantitative Trait Loci in Blood and Brain from Alzheimer Disease Study Participants.” Genes (Basel). 2021; PMID: 33804025

Patel D et al. “Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue.” Transl Psychiatry. 2021; PMID: 33907181

Patel N, Bush WS. “Modeling transcriptional regulation using gene regulatory networks based on multi-omics data sources.” BMC Bioinformatics. 2021; ; PMID: 33874910

Pillai JA et al. “TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer’s Disease.” Front Aging Neurosci. 2021; PMID: 33716716

Rajabli F et al. “Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus.” Neurobiol Aging. 2021; PMID: 33902942

Ramos J et al “Lower Levels of Education Are Associated with Cognitive Impairment in the Old Order Amish.” J Alzheimers Dis. 2021; PMID: 33285633

Sariya S et al. “Polygenic risk score for Alzheimer’s Disease in Caribbean Hispanics.” Ann Neurol. 2021; PMID: 34038570

Xue D et al. “Large-scale sequencing studies expand the known genetic architecture of Alzheimer’s disease.” Alzheimers Dement (Amst). 2021; PMID: 35005195

Zhang L et al. “Sex-specific DNA methylation differences in Alzheimer’s disease pathology.” Acta neruopathol Commun. 2021; PMID: 33902726

Zhang X et al. “Association of mitochondrial variants and haplogroups identified by whole exome sequencing with Alzheimer’s disease.” Alzheimers Dement. 2021; PMID: 34152079

CADRE publications for 2020

Bis JC et al. “Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation.” . Mol Psychiatry. 2020; PMID: 30108311

Bush WS et al. “Packaging Biocomputing Software to Maximize Distribution and Reuse.” Pac Symp Biocomput. 2020; PMID: 31797644

Bussies PL et al. “Use of Local Genetic Ancestry to Assess TOMM40-523′ and Risk for Alzhiemer Disease.” Neurol Genet. 2020; PMID: 32337333

Dumitrescu L et al. “Genetic variants and functional pathways associated with resiliance to Alzheimer’s disease” Brain. 2020; PMID: 32844198

Goldschmidt-Clermont PJ et al. “Time for Well-Powered Controlled Prospective Studies to Test a Causal Role for Herpes Viruses in Alzheimer’s Disease Using Antiherpetic Drugs” J Gerontol A Biol Sci Med Sci. 2020; PMID: 31175818

Griswold AJ et al. “Immune and Inflammatory Pathways Implicated by Whole Blood Transcriptomic Analysis in a Diverse Ancestry Alzheimer’s Disease Cohort.” J Alzheimers Dis. 2020; PMID: 32597797

Kunkle BW et al. “Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.” JAMA Neurol. 2020; PMID: 33074286

Lancour D et al. “Analysis of brain region-specific co-expression networks reveals clustering of established and novel genes associated with Alzheimer disease” Alzheimers Res Ther. 2020; PMID:  32878640

Reiman EM et al. “Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study.”  Nat Commun. 2020; PMID: 32015339

Sherva Ret al. “Genome-wide Association Study of Rate of Cognitive Decline in Alzheimer’s Disease Patients Identifies Novel Genes and Pathways.” Alzheimers Dement. 2020; PMID: 32573913

Tang ZZ et al. PSCAN: Spatial scan tests guided by protein structures improve complex disease gene discovery and signal variant detection.” Genome Biol. Aug 2020; PMID: 32847609

Vardarajan B et al. “Differences in Plasma Metabolites Related to Alzheimer’s Disease, APOE e4 Status, and Ethnicity.” Alzheimers Dement. 2020; PMID: 32377558

Wheeler NR et al. “Hadoop and PySpark for reproducibility and scalability of genomic sequencing studies.” Pac Symp Biocomput. 2020; PMID: 31797624

CADRE publications for 2018/19 

Beecham GW et al. Rare genetic variation implicated in non-Hispanic white families with Alzheimer disease. Neurol Genet. 2018; PMID: 30569016

Choi KY et al. “APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE e4 on Alzheimer’s Disease Risk in a Multiracial Sample.” J Clin Med. 2019; PMID: 31426376

Chung J et al. “Comparison of methods for multivariate gene-based association tests for complex diseases using common variants.” Eur J Hum Genet. 2019; PMID: 30683923

Dumitrescu L et al. “Sex differences in the genetic predictors of Alzheimer’s pathology.” Brain. 2019; PMID: 31497858

Gardner OK et al. “RNA editing alterations in a multi-ethnic Alzheimer disease cohort converge on immune and endocytic molecular pathways.” Hum Mol Genet. 2019; PMID: 31162550

Kunkle BW et al. “Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates AB, tau, immunity and lipid processing.” Nat Genet. 2019; PMID: 30820047

Ma Y et al. “Analysis of Whole-Exome Sequencing Data for Alzheimer Disease Stratified by APOE Genotype.” JAMA Neurol. 2019; PMID: 31180460

Ma Y et al. “CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.” Aging Cell. 2019; PMID: 31144443

Naj AC et al. “Quality Control and Integration of Genotypes from Two Calling Pipelines for Whole Genome Sequence Data in the Alzheimer’s Disease Sequencing Project.” Genomics. 2019; PMID: 29857119

Patel D et al. “Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry.” JAMA Netw Open. 2019; PMID: 30924900

Rajabli F et al. “Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.” PLoS Genet. 2018; PMID: 30517106

Sariya S et al. “Rare Variants Imputation in Admixed Populations: Comparison Across Reference Panels and Bioinformatics Tools.” Fron Genet. 2019; PMID: 31001313

Vardarajan BN et al. “Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer’s disease.” Ann Clin Transl Neurol. 2018; PMID: 29688227

Zhang X et al. “A rare missense variant of CASP7 is associated with familial late-onset Alzheimer’s disease.” Anzheimers Dement. Mar 2019; PMID: 30503768

CADRE Preprints

Chemparathy A et al. “APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s Disease pathology.” medRxiv. Jul 2023; PMID: 37547016

Guo MH et al. “Polygenic burden of short tandem repeat expansions promote risk for Alzheimer’s disease.” medRxiv. Nov 2023; PMID: 38014121

Lee WP et al. “Association of Common and Rare Variants with Alzheimer’s Disease in over 13,000 Diverse Individuals with Whole-Genome Sequencing from the Alzheimer’s Disease Sequencing Project.” medRxiv. 2023; PMID: 37693521

Lukacsovich D et al. “MIAMI-AD (Methylation in Aging and Methylation in AD): an integrative knowledgebase that facilitates explorations of DNA methylation across sex, aging, and Alzheimer’s disease.” medRxiv. 2023; PMID: 38105943

Main LR et al. “Genetic analysis of cognitive preservation in the midwestern Amish reveals a novel locus on chromosome 2.” MedRxiv. 2023; PMID: 38168325

Rajabli F et al. “African ancestry APOE e4 non-carriers with higher educational attainment are resilient to Alzheimer disease pathology-specific blood biomarker pTau181.” medRxiv. 2023; PMID: 37461667

Rajabli F et al. “Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium.” medRxiv. 2023; PMID: 37461624

Ray NR et al. “Extended genome-wide association study employing the African Genome Resources Panel identifies novel susceptibility loci for Alzheimer’s Disease in individuals of African ancestry.” medRxiv. 2023; PMID: 37693582

Wang D et al. Frequency Variants in Mendelian Alzheimer’s Disease Genes within the Alzheimer’s Disease Sequencing Project (ADSP).” medRxiv. 2023; PMID: 37961373

Wang H et al. “Structural Variation Detection and Association Analysis of Whole-Genome-Sequence Data from 16,905 Alzeheimer’s Disease Sequencing Project Subjects.” medRxiv. 2023; PMID: 37745545

Wang Y et al. Key variants via Alzheimer’s Disease Sequencing Project whole genome sequencing data.” medRxiv. 2023; PMID: 37693453

Zhang X et al. “An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer’s Disease.” bioRxiv. 2023; PMID: 37333116

Publications Using CADRE Resources

Amlie-Wolf A et al. “Inferring the Molecular Mechanisms of Noncoding Alzheimer’s Disease-Associated Genetic Variants.” J Alzheimers Dis. 2019; PMID: 31561366

Amlie-Wolf A et al. “Using INFERNO to Infer the Molecular Mechanisms Underlying Noncoding Genetic Associations.” Methods Mol Biol. 2021; PMID: 33326071

Chen HH et al. “GWAS and Beyond: Using Omics Approaches to Interpret SNP Associations.” Curr Genet Med Rep. Mar 2019; PMID: 33312764

Clark K et al. “Polygenic Risk Scores in Alzheimer’s Disease Genetics: Methodology, Applications, Inclusion, and Diversity.” J Alzheimers Dis. 2022; PMID: 35848019

Guen YL et al. “Association of African Ancestry-Specific APOE Missense Variant R145C With Risk of Alzheimer Disease.” JAMA. 2023; PMID: 36809323

Kuska PP et al. “Alzheimers’ Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer’s Disease.” J Alzheimers Dis. 2022; PMID: 35068457

Mantyh WG et al. “Early-onset Alzheimer’s disease explained by polygenic risk of late-onset disease?” Alzheimers Dement (Amst). 2023; PMID: 37780862

O’Neill NK et al. “Bulk brain tissue cell-type deconvolution with bias correction for single-nuclei RNA sequencing data using DeTREM.” BMC Bioinformatics. Sep 2023; PMID: 37726653

You Y et al. “Alzheimer’s disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR-edited human neuronal cells.” Aging Cell. Jun 2022; PMID: 35567427

Zhang L et al. “Epigenome-wide meta-analysis of DNA methylation differences in prefrontoal cortex implicates the immune processes in Alzheimer’s disease.” Nat Commun. Nov 2020; PMID: 33257653

CADRE Investigators’ Other AD Publications:

Ally M et al. “Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer’s disease.” Alzheimers Dement (Amst). 2023 Oct 25;15(4):e12492. doi: 10.1002/dad2.12492.

Belloy ME et al. “APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry.” JAMA Neurol. 2023 Dec 1;80(12):1284-1294. doi: 10.1001/jamaneurol.2023.3599.

Byfield G et al. “Leveraging African American family connectors for Alzheimer’s disease genomics studies.” Alzheimers Dement. 2023 Dec;19(12):5437-5446. doi: 10.1002/alz.13106.

Caban-Holt A et al. “Attitudes and Perceptions about Brain Donation Among African Americans: Implications for Recruitment into Alzheimer’s Disease Research.” J Alzheimers Dis. 2024;97(4):1621-1627. doi: 10.3233/JAD-230461.

Cheng F et al. “Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease.” Cell Rep Med.  2024 Feb 20;5(2):101379. doi: 10.1016/j.xcrm.2023.101379.

Chung J et al. “Alzheimer’s disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.” Alzheimers Dement. 2023 Nov;19(11):5173-5184. doi: 10.1002/alz.13069.

Cukier HN et al. “An Alzheimer’s disease risk variant in TTC3 modifies the actin cytoskeleton organization and the PI3K-Akt signaling pathway in iPSC-derived forebrain neurons.” Neurobiol Aging. 2023 Nov:131:182-195. doi: 10.1016/j.neurobiolaging.2023.07.007.

Cukier HN et al. “Generation of an induced pluripotent stem cell line (UMio43-A) from an African American patient with Alzheimer’s disease carrying an ABCA7 deletion (p.Arg578Alafs).” Stem Cell Res. 2024 Apr:76:103364. doi: 10.1016/j.scr.2024.103364.

Greenfest-Allen E et al. “NIAGADS Alzheimer’s GenomicsDB: A resource for exploring Alzheimer’s disease genetic and genomic knowledge.” Alzheimers Dement. 2024 Feb;20(2):1123-1136. doi: 10.1002/alz.13509.

Ho P-C et al. “Asian Cohort for Alzheimer’s Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer’s disease among Asian Americans and Canadians.” Alzheimers Dement. 2024 Mar;20(3):2058-2071. doi: 10.1002/alz.13611.

Kalaria R et al. “The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact.” Alzheimers Dement. 2024 May 2. doi: 10.1002/alz.13836. Online ahead of print.

Osterman MD et al. “Founder population-specific weights yield improvements in performance of polygenic risk scores for Alzheimer disease in the Midwestern Amish.” HGG Adv. 2023 Oct 12;4(4):100241. doi: 10.1016/j.xhgg.2023.100241.

Panitch R et al. “APOE genotype-specific methylation patterns are linked to Alzheimer disease pathology and estrogen response.” Transl Psychiatry. 2024 Feb 29;14(1):129. doi: 10.1038/s41398-024-02834-x.

Rajabli R et al. “African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer’s Disease Measured by pTau181.” J Alzheimers Dis. 2024;98(1):221-229. doi: 10.3233/JAD-231116.

Rehman H et al. “Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status.” J Alzheimers Dis. 2024;97(2):621-633. doi: 10.3233/JAD-230837.

Tao Q et al. “Identification of an APOE e4-specific blood-based molecular pathway for Alzheimer’s disease risk.” Alzheimers Dement (Amst). 2023 Oct 16;15(4):e12490. doi: 10.1002/dad2.12490.

Wang Y et al. “The association between circulating CD34+ CD133+ endothelial progenitor cells and reduced risk of Alzheimer’s disease in the Framingham Heart Study.” Explor Med. 2024;5(2):193-214. doi: 10.37349/emed.2024.00216.

Xicota L et al. Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer’s disease.” Alzheimers Dement. 2024 Apr;20(4):2670-2679. doi: 10.1002/alz.13718.

Yan D et al. “Biobank-wide association scan identifies risk factors for late-onset Alzheimer’s disease and endophenotypes.” Elife. 2024 May 24:12:RP91360. doi: 10.7554/eLife.91360.